Influence of glucocorticoids on human osteoclast generation and activity

Journal of Bone and Mineral Research

Volumn 20, Issue 3, 2005, Pages 390-398

  Sivagurunathan, Sutharshani ^a   Muir, Meloni M ^a   Brennan, Tara C ^a   Seale, J Paul ^a,b   Mason, Rebecca S ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

^b University of Sydney   (Australia)

Author keywords

Dexamethasone; Glucocorticoids; Human peripheral blood mononuclear cell; Osteoprotegerin; RANKL

Indexed keywords

COLONY STIMULATING FACTOR 1; DEXAMETHASONE; GLUCOCORTICOID; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN;

ARTICLE; BONE DEVELOPMENT; CELL ACTIVITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STIMULATION; CELL SURVIVAL; CONTROLLED STUDY; CORTICOSTEROID INDUCED OSTEOPOROSIS; CORTICOSTEROID THERAPY; CULTURE MEDIUM; DENTIN; DOSE RESPONSE; DRUG EFFECT; HUMAN; HUMAN CELL; OSSIFICATION; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPECIES DIFFERENCE; STEM CELL;

CARRIER PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; DEXAMETHASONE; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; HUMANS; LEUKOCYTES, MONONUCLEAR; MACROPHAGE COLONY-STIMULATING FACTOR; MEMBRANE GLYCOPROTEINS; OSTEOCLASTS; OSTEOGENESIS; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B;

EID: 14344250168     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/JBMR.041233     Document Type: Article

References (68)

1. Dempster DW 1989 Bone histomorphometry in glucocorticoid-induced osteoporosis. J Bone Miner Res 4:137-141.
2. Dalle Carbonare L, Arlot ME, Chavassieux PM, Roux JP, Portero NR, Meunier PJ 2001 Comparison of trabecular bone microarchitecture and remodeling in glucocorticoid-induced and postmenopausal osteoporosis. J Bone Miner Res 16:97-103.
3. Bressot C, Meunier PJ, Chapuy MC, Lejeune E, Edouard C, Darby AJ 1979 Histomorphometric profile, pathophysiology and reversibility of corticosteroid-induced osteoporosis. Metab Bone Dis Relat Res 1:303-311.
4. Chappard D, Legrand E, Basle MF, Fromont P, Racineux JL, Rebel A, Audran M 1996 Altered trabecular architecture induced by corticosteroids: A bone histomorphometric study. J Bone Miner Res 11:676-685.
5. Van Staa TP, Leufkens HG, Abenhaim L, Zhang B, Cooper C 2000 Use of oral corticosteroids and risk of fractures. J Bone Miner Res 15:993-1000.
6. Lukert BP, Raisz LG 1990 Glucocorticoid-induced osteoporosis: Pathogenesis and management. Ann Intern Med 112:352-364.
7. Namkung-Matthai H, Seale JP, Brown K, Mason RS 1998 Comparative effects of anti-inflammatory corticosteroids in human bone-derived osteoblast-like cells. Eur Respir J 12:1327-1333.
8. Weinstein RS 1998 Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone. J Clin Invest 102:274-282.
9. Sambrook P, Hughes D, Nelson AE, Robinson BG, Mason RS 2003 Osteocyte viability with glucocorticoid therapy: Relation to histomorphometry. Ann Rheum Dis 62:1215-1217.
10. Weinstein RS, Chen JR, Powers CC, Stewart SA, Landes RD, Bellido T, Jilka RL, Parfitt AM, Manolagas SC 2002 Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids. J Clin Invest 109:1041-1048.
11. Manolagas SC 2000 Corticosteroids and fractures: A close encounter of the third cell kind. J Bone Miner Res 15:1001-1005.
12. Udagawa N, Takahashi N, Akatsu T, Tanaka H, Sasaki T, Nishihara T, Koga T, Martin TJ, Suda T 1990 Origin of osteoclasts: Mature monocytes and macrophages are capable of differentiating into osteoclasts under a suitable microenvironment prepared by bone marrow-derived stromal cells. Proc Natl Acad Sci USA 87:7260-7264.
13. Elford PR, Felix R, Cecchini M, Trechsel U, Fleisch H 1987 Murine osteoblast-like cells and the osteogenic cell MC3T3-E1 release a macrophage colony-stimulating activity in culture. Calcif Tissue Int 41:151-156.
14. Yasuda H, Shima N, Nakagawa N, Mochizuki SI, Yano K, Fujise N, Sato Y, Goto M, Yamaguchi K, Kuriyama M, Kanno T, Murakami A, Tsuda E, Morinaga T, Higashio K 1998 Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 139:1329-1337.
15. Raisz LG, Trummel CL, Wener JA, Simmons H 1972 Effect of glucocorticoids on bone resorption in tissue culture. Endocrinology 90:961-967.
16. Teitelbaum SL, Malone JD, Kahn AJ 1981 Glucocorticoid enhancement of bone resorption by rat peritoneal macrophages in vitro. Endocrinology 108:795-799.
17. Reid IR, Katz JM, Ibbertson HK, Gray DH 1986 The effects of hydrocortisone, parathyroid hormone and the bisphosphonate, APD, on bone resorption in neonatal mouse calvaria. Calcif Tissue Int 38:38-43.
18. Tobias J, Chambers TJ 1989 Glucocorticoids impair bone resorptive activity and viability of osteoclasts disaggregated from neonatal rat long bones. Endocrinology 125:1290-1295.
19. Minkin C 1982 Bone acid phosphatase: Tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif Tissue Int 34:285-290.
20. Howard CV, Reed MG 1998 Unbiased Stereology: Three Dimensional Measurement in Microscopy. BIOS Scientific Publishers, Oxford, UK.
21. Slater M, Patava J, Kingham K, Mason RS 1994 Modulation of growth factor incorporation into ECM of human osteoblast-like cells in vitro by 17 beta-estradiol. Am J Physiol 267:E990-E1001.
22. Smith RD, Brown B, Ikonomi P, Schechter AN 2003 Exogenous reference RNA for normalization of real-time quantitative PCR. Biotechniques 34:88-91.
23. Weigelt J, Brown SE, Miles CS, Dixon NE, Otting G 1999 NMR structure of the N-terminal domain of E. coli DnaB helicase: Implications for structure rearrangements in the helicase hexamer. Structure 7:681-690.
24. Tricarico C, Pinzani P, Bianchi S, Paglierani M, Distante V, Pazzagli M, Bustin SA, Orlando C 2002 Quantitative real-time reverse transcription polymerase chain reaction: Normalization to rRNA or single housekeeping genes is inappropriate for human tissue biopsies. Anal Biochem 309:293-300.
25. Bustin SA 2002 Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): Trends and problems. J Mol Endocrinol 29:23-39.
26. Tsubakihara M, Williams NK, Keogh A, dos Remedies CG 2004 Comparison of gene expression between left atria and left ventricles from non-diseased humans. Proteomics 4:261-270.
27. Colquhoun D 1971 Lectures on Biostatistics-An Introduction to Statistics with Applications in Biology and Medicine. Clarendon Press, Oxford, UK.
28. Efstratiadis T, Moss DW 1985 Tartrate-resistant acid phosphatase of human lung: Apparent identity with osteoclastic acid phosphatase. Enzyme 33:34-40.
29. Chambers JP, Peters SP, Glew RH, Lee RE, McCafferty LR, Mercer DW, Wenger DA 1978 Multiple forms of acid phosphatase activity in Gaucher's disease. Metabolism 27:801-814.
30. Snipes RG, Lam KW, Dodd RC, Gray TK, Cohen MS 1986 Acid phosphatase activity in mononuclear phagocytes and the U937 cell line: Monocyte-derived macrophages express tartrate-resistant acid phosphatase. Blood 67:729-734.
31. Horton MA, Rimmer EF, Chambers TJ 1986 Giant cell formation in rabbit long-term bone marrow cultures: Immunological and functional studies. J Bone Miner Res 1:5-14.
32. Burger EH, van der Meer JW, Nijweide PJ 1984 Osteoclast formation from mononuclear phagocytes: Role of bone-forming cells. J Cell Biol 99:1901-1906.
33. Ali NN, Boyde A, Jones SJ 1984 Motility and resorption: Osteoclastic activity in vitro. Anat Embryol 170:51-56.
34. Allen TD, Testa NG, Suda T, Schor SL, Onions D, Jarrett O, Boyde A 1981 The production of putative osteoclasts in tissue culture-ultrastructure, formation and behavior. Scan Electron Microsc Pt.3:347-354.
35. Lukert BP, Raisz LG 1994 Glucocorticoid-induced osteoporosis. Rheum Dis Clin North Am 20:629-650.
36. Reid IR, Veale AG, France JT 1994 Glucocorticoid osteoporosis. J Asthma 31:7-18.
37. Adler RA, Rosen CJ 1994 Glucocorticoids and osteoporosis. Endocrinol Metab Clin North Am 23:641-654.
38. Kim CH, Cheng SL, Kim GS 1999 Effects of dexamethasone on proliferation, activity, and cytokine secretion of normal human bone marrow stromal cells: Possible mechanisms of glucocorticoid-induced bone loss. J Endocrinol 162:371-379.
39. Fucik RF, Kukreja SC, Hargis GK, Bowser EN, Henderson WJ, Williams GA 1975 Effect of glucocorticoids on function of the parathyroid glands in man. J Clin Endocrinol Metab 40:152-155.
40. Klein RG, Arnaud SB, Gallagher JC, Deluca HF, Riggs BL 1977 Intestinal calcium absorption in exogenous hypercortisonism. Role of 25-hydroxyvitamin D and corticosteroid dose. J Clin Invest 60:253-259.
41. Suzuki Y, Ichikawa Y, Saito E, Homma M 1983 Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy. Metabolism 32:151-156.
42. Slovik DM, Neer RM, Ohman JL, Lowell FC, Clark MB, Segre GV, Potts JT Jr 1980 Parathyroid hormone and 25-hydroxy-vitamin D levels in glucocorticoid- treated patients. Clin Endocrinol 12:243-248.
43. Paz-Pacheco E, Fuleihan GE, LeBoff MS 1995 Intact parathyroid hormone levels are not elevated in glucocorticoid-treated subjects. J Bone Miner Res 10:1713-1718.
44. Luengo M, Picado C, Piera C, Guanabens N, Montserrat JM. Rivera J, Setoain J 1991 Intestinal calcium absorption and parathyroid hormone secretion in asthmatic patients on prolonged oral or inhaled steroid treatment. Eur Respir J 4:441-444.
45. Hattersley AT, Meeran K, Burrin J, Hill P, Shiner R, Ibbertson HK 1994 The effect of long- and short-term corticosteroids on plasma calcitonin and parathyroid hormone levels. Calcif Tissue Int 54:198-202.
46. Stern PH 1969 Inhibition by steroids of parathyroid hormone-induced Ca45 release from embryonic rat bone in vitro. J Pharmacol Exp Ther 168:211-217.
47. Udagawa N, Takahashi N, Akatsu T, Sasaki T, Yamaguchi A, Kodama H, Martin TJ, Suda T 1989 The bone marrow-derived stromal cell lines MC3T3-G2/PA6 and ST2 support osteoclast-like cell differentiation in cocultures with mouse spleen cells. Endocrinology 125:1805-1813.
48. Shuto T, Kukita T. Hirata M, Jimi E, Koga T 1994 Dexamethasone stimulates osteoclast-like cell formation by inhibiting granulocyte-macrophage colony-stimulating factor production in mouse bone marrow cultures. Endocrinology 134:1121-1126.
49. Fuller K, Wong B, Fox S, Choi Y, Chambers TJ 1998 TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts. J Exp Med 188:997-1001.
50. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliott G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ 1998 Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165-176.
51. Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, Morony S, Oliveira-dos-Santos AJ, Van G, Itie A, Khoo W, Wakeham A, Dunstan CR, Lacey DL, Mak TW, Boyle WJ, Penninger JM 1999 OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397:315-323.
52. Hsu H, Lacey DL, Dunstan CR, Solovyev I, Colombero A, Timms E, Tan HL, Elliott G, Kelley MJ, Sarosi I, Wang L, Xia XZ, Elliott R, Chiu L, Black T, Scully S, Capparelli C, Morony S, Shimamoto G, Bass MB, Boyle WJ 1999 Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci USA 96:3540-3545.
53. Matsuzaki K, Udagawa N, Takahashi N, Yamaguchi K, Yasuda H, Shima N, Morinaga T, Toyama Y, Yabe Y, Higashio K, Suda T 1998 Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures. Biochem Biophys Res Commun 246:199-204.
54. Quinn JM, Fujikawa Y, McGee JO, Athanasou NA 1997 Rodent osteoblast-like cells support osteoclastic differentiation of human cord blood monocytes in the presence of M-CSF and 1,25 dihydroxyvitamin D3. Int J Biochem Cell Biol 29:173-179.
55. Hirayama T, Sabokbar A, Athanasou NA 2002 Effect of corticosteroids on human osteoclast formation and activity. J Endocrinol 175:155-163.
56. Sivagurunathan S, Muir MM, Seale JP, Mason RS 2002 Direct Effects of Dexamethasone on Osteoclasts and Precursors. 8th Annual Scientific Meeting, Australian and New Zealand Orthopaedic Research Society, Melbourne, Australia.
57. O'Sullivan BT, Cutler DJ, Hunt GE, Walters C, Johnson GF, Caterson ID 1997 Pharmacokinetics of dexamethasone and its relationship to dexamethasone suppression test outcome in depressed patients and healthy control subjects. Biol Psychiatry 41:574-584.
58. Luttrell BM Laboratory Test Guide. Royal North Shore Hospital, Department of Endocrinology, Sydney, Australia.
59. Dempster DW, Moonga BS, Stein LS, Herbert WR, Antakly T 1997 Glucocorticoids inhibit bone resorption by isolated rat osteoclasts by enhancing apoptosis. J Endocrinol 154:397-406.
60. Huang L, Xu J, Kumta SM, Zheng MH 2001 Gene expression of glucocorticoid receptor alpha and beta in giant cell tumour of bone: Evidence of glucocorticoid-stimulated osteoclastogenesis by stromal-like tumour cells. Mol Cell Endocrinol 181:199-206.
61. Quinn JM, Elliott J, Gillespie MT, Martin TJ 1998 A combination of osteoclast differentiation factor and macrophage-colony stimulating factor is sufficient for both human and mouse osteoclast formation in vitro. Endocrinology 139:4424-4427.
62. Bord S, Ireland DC, Beavan SR, Compston JE 2003 The effects of estrogen on osteoprotegerin, RANKL, and estrogen receptor expression in human osteoblasts. Bone 32:136-141.
63. Cheung J, Mak YT, Papaioannou S, Evans BA, Fogelman I, Hampson G 2003 Interleukin-6 (IL-6), IL-1, receptor activator of nuclear factor kappaB ligand (RANKL) and osteoprotegerin production by human osteoblastic cells: Comparison of the effects of 17-beta oestradiol and raloxifene. J Endocrinol 177:423-433.
64. Vidai NO, Brandstrom H, Jonsson KB, Ohlsson C 1998 Osteoprotegerin mRNA is expressed in primary human osteoblast-like cells: Down-regulation by glucocorticoids. J Endocrinol 159:191-195.
65. Hofbauer LC, Gori F, Riggs BL, Lacey DL, Dunstan CR, Spelsberg TC, Khosla S 1999 Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: Potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Endocrinology 140:4382-4389.
66. Simonet WS 1997 Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. J Thorac Cardiovasc Surg 113:413-414.
67. Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C, Scully S, Tan HL, Xu W, Lacey DL, Boyle WJ, Simonet WS 1998 osteoprotegerin-defident mice develop early onset osteoporosis and arterial calcification. Genes Dev 12:1260-1268.
68. Rubin MR, Bilezikian JP 2002 The role of parathyroid hormone in the pathogenesis of glucocorticoid-induced osteoporosis: A re-examination of the evidence. J Clin Endocrinol Metab 87:4033-4041.